PMID: 9435913Nov 1, 1994Paper

Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence

Experimental Gerontology
R B EffrosF Schächter

Abstract

The dramatic decline in immune function with age, especially in T cell proliferative activity, has been documented extensively in experimental animal models and in clinical studies of the elderly. A similar proliferative decline is also seen in long-term T lymphocyte cultures used to study in vitro cellular senescence. We have compared the peripheral blood T lymphocytes of centenarians and younger controls for the cell surface expression of CD28, a costimulatory molecule that is required for optimal activation and proliferation following engagement of the T cell receptor. Our analysis shows a significant decrease (p < 0.001) in the percentage of T cells expressing CD28 in the elderly cohort, with values ranging from 44% to 90%, as compared to the mean control value of 91%. The decline in the percentage of CD28+ T cells correlates with a reduction in the CD4/CD8 ratio (r2 = 0.695, p < 0.0001). Concommitantly, experiments using an in vitro T cell culture system showed a progressive loss of CD28 expression with culture "age." The concordance of proliferative decline and loss of CD28 in the centenarians and in the in vitro cultures suggest that a Hayflick phenomenon may operate in vivo leading to immunosenescence.

References

Nov 19, 1992·Nature·C A MichieP C Beverley
Jan 1, 1989·Advances in Immunology·M L Thoman, W O Weigle
Jan 1, 1989·Experimental Gerontology·N L PerilloR B Effros
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M SiekevitzW C Greene
Mar 1, 1965·Experimental Cell Research·L HAYFLICK

❮ Previous
Next ❯

Citations

Oct 1, 1996·Journal of General Internal Medicine·A C Justice, C Whalen
Jul 3, 2002·Aging Clinical and Experimental Research·Bernard Jeune
May 13, 2011·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A M TyagiD Singh
Dec 30, 2006·Rheumatology International·Melissa PadovanFrancesco Trotta
Feb 28, 2008·Medical Microbiology and Immunology·Edward C P WallerMark R Wills
May 30, 2009·Age·Sian M Henson, Arne N Akbar
Aug 25, 2010·Immunologic Research·Tammy M Rickabaugh, Beth D Jamieson
Jun 7, 2013·Aging Clinical and Experimental Research·Huanjiu XiLuping Zhang
Sep 15, 1995·Mechanisms of Ageing and Development·M AdibzadehG Pawelec
Oct 25, 1996·Mechanisms of Ageing and Development·M AdibzadehG Pawelec
Jan 1, 1995·Molecular Aspects of Medicine·S I Rattan
Mar 31, 2004·Experimental Gerontology·Sudhir GuptaSastry Gollapudi
Mar 31, 2004·Experimental Gerontology·Elissaveta NaumovaDaniela Baltadjieva
Dec 31, 2003·Experimental Gerontology·Rita B EffrosHector F Valenzuela
Mar 31, 2004·Experimental Gerontology·Agnieszka BrzezińskaEwa Sikora
Mar 24, 2004·Mechanisms of Ageing and Development·Rita B Effros
Jun 16, 2000·Mechanisms of Ageing and Development·J L FaheyP Nishanian
Feb 13, 2001·Mechanisms of Ageing and Development·A N AkbarM Salmon
Feb 13, 2001·Mechanisms of Ageing and Development·J D McLeod
Feb 13, 2001·Mechanisms of Ageing and Development·R B Effros
Aug 21, 2001·Mechanisms of Ageing and Development·G PawelecT Fülöp
Nov 24, 2001·Mechanisms of Ageing and Development·Thomas PerlsAnnibale Puca
Mar 6, 2003·Mechanisms of Ageing and Development·Rita B Effros
Apr 26, 2003·Mechanisms of Ageing and Development·Agnieszka BrzezińskaEwa Sikora
Aug 28, 1998·Mechanisms of Ageing and Development·Y A Barnett, C R Barnett
Sep 2, 1998·Mechanisms of Ageing and Development·G M CrisiG J Thorbecke
Feb 17, 1998·Developmental and Comparative Immunology·R B Effros
Mar 17, 2001·Archives of Gerontology and Geriatrics·L MalaguarneraA Messina
Jul 26, 2008·Archives of Gerontology and Geriatrics·C TortorellaS Antonaci
Oct 24, 2002·Human Immunology·Urban J ScheuringArgyrios N Theofilopoulos
Feb 26, 2000·Vaccine·R B Effros
Feb 26, 2000·Vaccine·R G Webster
Feb 28, 2001·Experimental Gerontology·V R PorterR B Effros
Jan 5, 2002·Experimental Gerontology·Olga DelaRosaRafael Solana
Jan 5, 2002·Experimental Gerontology·Graham PawelecRafael Solana

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.